CREDIT SUISSE AG/ - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 255 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$3,751,671
-8.7%
98,237
-1.7%
0.00%0.0%
Q2 2023$4,110,615
-23.2%
99,942
+7.2%
0.00%
-20.0%
Q1 2023$5,352,966
+8.8%
93,241
+6.3%
0.01%0.0%
Q4 2022$4,919,919
+69.8%
87,746
+28.3%
0.01%
+66.7%
Q3 2022$2,897,000
-17.4%
68,398
+5.3%
0.00%
-25.0%
Q2 2022$3,508,000
-19.7%
64,935
-4.5%
0.00%0.0%
Q1 2022$4,371,000
+5.6%
68,022
+10.1%
0.00%
+100.0%
Q4 2021$4,141,000
-15.8%
61,810
-14.0%
0.00%
-33.3%
Q3 2021$4,919,000
+3.8%
71,849
+3.4%
0.00%0.0%
Q2 2021$4,741,000
-14.2%
69,476
-13.1%
0.00%0.0%
Q1 2021$5,527,000
+13.1%
79,984
+6.2%
0.00%
+50.0%
Q4 2020$4,887,000
-25.9%
75,286
-46.1%
0.00%
-50.0%
Q3 2020$6,596,000
-6.0%
139,692
-6.5%
0.00%
-20.0%
Q2 2020$7,019,000
+2.9%
149,373
-2.2%
0.01%
-16.7%
Q1 2020$6,823,000
+48.7%
152,732
+94.0%
0.01%
+100.0%
Q4 2019$4,588,000
-19.8%
78,725
-17.4%
0.00%
-40.0%
Q3 2019$5,724,000
-16.4%
95,283
-22.3%
0.01%
-16.7%
Q2 2019$6,845,000
+101.2%
122,556
+100.7%
0.01%
+100.0%
Q1 2019$3,402,000
+74.8%
61,061
+41.5%
0.00%
+50.0%
Q4 2018$1,946,000
-48.0%
43,151
-24.1%
0.00%
-33.3%
Q3 2018$3,745,000
+22.3%
56,858
+19.6%
0.00%0.0%
Q2 2018$3,063,000
-11.1%
47,549
-23.6%
0.00%0.0%
Q1 2018$3,445,000
-17.5%
62,271
-28.6%
0.00%
-25.0%
Q4 2017$4,175,000
-6.7%
87,254
-1.5%
0.00%0.0%
Q3 2017$4,473,000
-60.9%
88,617
-57.8%
0.00%
-63.6%
Q2 2017$11,441,000
+10.9%
209,896
-14.3%
0.01%
+22.2%
Q1 2017$10,312,000
+244.9%
244,793
+602.2%
0.01%
+200.0%
Q4 2016$2,990,000
-4.8%
34,863
-8.4%
0.00%0.0%
Q3 2016$3,142,000
+28.0%
38,061
+23.7%
0.00%0.0%
Q2 2016$2,455,000
+90.2%
30,773
+60.6%
0.00%
+50.0%
Q1 2016$1,291,000
-5.5%
19,165
-4.9%
0.00%0.0%
Q4 2015$1,366,000
+18.4%
20,152
+3.9%
0.00%
+100.0%
Q3 2015$1,154,000
-66.8%
19,387
-62.4%
0.00%
-66.7%
Q2 2015$3,472,000
+358.7%
51,553
+320.1%
0.00%
+200.0%
Q1 2015$757,000
+27.2%
12,271
+11.8%
0.00%0.0%
Q4 2014$595,000
-0.5%
10,976
-8.9%
0.00%
Q3 2014$598,000
-23.4%
12,049
-27.4%
0.00%
-100.0%
Q2 2014$781,000
+27.0%
16,587
+23.9%
0.00%0.0%
Q1 2014$615,000
-35.7%
13,385
-33.2%
0.00%0.0%
Q4 2013$957,000
+50.2%
20,035
+26.6%
0.00%0.0%
Q3 2013$637,000
+58.1%
15,824
+53.1%
0.00%
Q1 2013$403,00010,3390.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q4 2020
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders